Search Results 1191-1200 of 18761 for Relapse

  1. A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors - Mayo Clinic

    Have histologically- or cytologically-confirmed disease, which is relapsed/ refractory, and unresectable or metastatic disease, following at least 1 prior ...

  2. Focus areas - Liquid Biopsy and Translational Immunogenomics: Aadel A. Chaudhuri - Mayo Clinic Research

    MRD detection from proximal biofluids to anticipate cancer relapse. Oligometastatic cancer risk stratification. Precision oncology. More about research at ...

  3. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic to offer CAR T-cell therapy for relapsed non-Hodgkin lymphoma featured. Cancer. Mayo Clinic to offer CAR T-cell therapy for relapsed non-Hodgkin ...

  4. Mayo Clinic Q&A podcast: Advances in managing MS

    These relapses are followed by quiet periods of disease remission that can last months or even years. While there is no cure, treatments can help modify the ...

  5. Selinexor (oral route) - Side effects & dosage - Mayo Clinic

    It is also used together with dexamethasone to treat multiple myeloma that has come back (relapsed) or has not responded to treatment (refractory) in ...

  6. Mayo Clinic Q and A: Treating melasma

    Unlike the set 100% coverage of intense-pulsed light, these lasers can treat as low as 5% of the skin to slowly remove pigment with a much lower risk of relapse ...

  7. Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) - Diagnosis and treatment - Mayo Clinic

    Treatment typically focuses on speeding recovery from attacks, managing symptoms and reducing relapses. You meet with your healthcare team to come up with a ...

  8. Hematology - Clinical trials

    This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory ...

  9. A Study to Evaluate Brigatinib Before Brain Irradiation - Mayo Clinic

    ... relapse-free with at least 3 years elapsed since the diagnosis of the other primary malignancy. Participating Mayo Clinic locations. Study statuses change ...

  10. Mayo Clinic Health Letter: Highlights from the July 2014 Issue

    About 10 percent of study participants had a relapse of depression symptoms. Research is underway to determine possible changes to TMS delivery that may ...